Oslo, Norway, 23 May 2024
In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 23th of May, the Company’s Chair of the Board, Øyvin Brøymer, has received open proxies to represent a total of 5 576 864 shares in the Company at the AGM, corresponding to 12.58% of the total number of votes and shares in the Company. Together with the 12 575 000 shares held by Øyvin Brøymer through Intertrade Shipping AS, he will represent a total of 18 151 864 votes at the AGM, corresponding to a total of 40,93% of the total number of shares and votes in the Company. The proxies are only valid for the AGM and will lapse thereafter.
NEW YORK, Feb. 2, 2026 /PRNewswire/ -- The Global IoT in Healthcare Market is entering…
MURFREESBORO, TN / ACCESS Newswire / February 2, 2026 / National Health Investors, Inc. (NYSE:NHI)…
Access to an audience of over 19 million individuals monthly will expand national exposure, and…
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…